Drug companies spend $109 million to block vote to lower drug prices

Big pharmaceutical companies are fighting “tooth and nail” to stop California voters from approving Prop 61, which could lower drug prices, writes Harriet Blair Rowan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.